Unihealth Consultancy Ltd

Unihealth Consul Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Unihealth Consultancy Ltd

₹ 133 0.00%
26 Apr - close price
Company website NSE - SM : UNIHEALTH
About

Incorporated in 2010, Unihealth Consultancy Limited is a healthcare service provider based out of Mumbai and has operational presence across a few countries in the African Continent.[1]

Key Points

Business segments[1] Unihealth Consultancy's business segments include Medical Centres, Hospitals, Consultancy Services, Distribution of Pharmaceutical and medical Consumable Products, and Medical Value Travel.

Website NSE - SM
  • Market Cap ₹ 205 Cr.
  • Current Price ₹ 133
  • High / Low ₹ 166 / 116
  • Stock P/E 26.8
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 22.4 %
  • ROE 36.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 38.7%

Cons

  • Company has high debtors of 228 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023
22.10
15.01
Operating Profit 7.09
OPM % 32.08%
0.75
Interest 1.53
Depreciation 1.14
Profit before tax 5.17
Tax % 17.02%
4.25
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
22.23 26.21 36.83 43.94
20.08 19.69 25.31 30.12
Operating Profit 2.15 6.52 11.52 13.82
OPM % 9.67% 24.88% 31.28% 31.45%
0.88 2.43 1.09 2.09
Interest 1.75 1.29 5.19 4.12
Depreciation 2.19 2.18 2.21 2.52
Profit before tax -0.91 5.48 5.21 9.27
Tax % -2.20% 9.49% 27.06% 17.48%
-0.95 4.92 3.72 7.66
EPS in Rs
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 26%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 112%
TTM: 105%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 39%
Last Year: 36%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 1.34 1.34 1.34 1.39 15.40
Reserves 4.34 9.36 13.45 26.13 65.20
40.68 38.71 38.01 39.27 28.66
11.98 8.98 11.98 11.54 15.21
Total Liabilities 58.34 58.39 64.78 78.33 124.47
35.45 35.19 35.84 37.08 36.01
CWIP 2.11 0.46 0.49 0.00 0.00
Investments 0.39 0.36 0.28 0.29 0.25
20.39 22.38 28.17 40.96 88.21
Total Assets 58.34 58.39 64.78 78.33 124.47

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
0.66 4.06 9.34 1.33
-1.38 0.05 -3.16 -5.07
1.19 -3.25 -5.88 3.35
Net Cash Flow 0.48 0.85 0.30 -0.40

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 206.06 197.61 180.27 227.52
Inventory Days 50.32 85.81 78.31 105.79
Days Payable 381.77 91.10 78.74 148.41
Cash Conversion Cycle -125.39 192.32 179.84 184.91
Working Capital Days 114.44 161.82 146.28 169.21
ROCE % 14.16% 20.42% 22.45%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024
68.80% 68.80%
5.61% 0.00%
3.31% 0.14%
22.27% 31.05%
No. of Shareholders 1,111979

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

Credit ratings